Dr. Loubna Bouarfa, an esteemed machine learning scientist and entrepreneur, founded
OKRA.ai, utilizing AI to streamline drug delivery systems, ensuring swift and accurate
patient treatment. After OKRA.ai's 2023 acquisition, she is now the Chairwoman of the AI Innovation Board at Envision Pharma Group, leading AI integration into life sciences with visionary leadership.
She impacts business innovation, policymaking, and academia, earning recognition in
Forbes' Top 50 Women in Tech and as a Top Innovator Under 35 by MIT Technology Review.
She received CEO of the Year 2019 at the Cambridge Independent Science and Technology
Awards.
Deeply engaged in international AI policy, she contributed as a pivotal member of the High-
Level Expert Group to EU ethical guidelines and advises global organizations like the UN and UNESCO, ensuring responsible AI development.
Transitioning from academia at Imperial College London, she advises at the Oxford Internet
Institute, focusing on AI's societal impacts and policy implications. Partnering with
Cambridge University in 2024, she delivers lectures on Applied AI and Entrepreneurship,
blending theory with practical insights, preparing students for thoughtful and ethical AI
application in business contexts.”